Close Menu

iSentio

With the expansion and new hires, the company is making good on an earlier promise to use a $1.5 million financing round to increase its customer base in the US and European clinical markets.

Norway's iSentio is looking to expand the customer base for its web-based bacterial identification software and add additional support for existing subscribers in the US and Europe.

Paired Ends: Dec 14, 2010

Premium

Siri Fürst, Greg Critchfield

The company will use the funds to expand commercialization of its RipSeq software.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.